Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Other Operating Expenses (2025)

Updated

Adaptin Bio's Other Operating Expenses came in at $138,167 for Q2 2026, down 59.4% from $340,334 a year earlier and down 16.6% from the prior quarter.

Analysis

Adaptin Bio (APTN) Other Operating Expenses (2025) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Adaptin Bio reported Other Operating Expenses of $1.68 million, up 24.7% year-over-year; for FY2025, it was $1.77 million, down 2.8% from FY2024.

  • Going back by year, Other Operating Expenses was $1.82 million in FY2024.
  • The Q2 2026 figure represents the lowest quarterly Other Operating Expenses since Q1 2025.
  • Year-over-year, Other Operating Expenses increased in three of the last six quarters, with growth averaging 22.0%.
  • Business Quant data shows APTN's Other Operating Expenses at $165,577 (Q1 2026), $593,035 (Q4 2025) and $778,664 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 180,000.00
API Access

Adaptin Bio Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=APTN&period=max&api_key=YOUR_API_KEY